Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, LIC

ePlus Announces AI Ignite: Artificial Intelligence Assessment, Enablement and Implementation Offerings


Provides support throughout the AI journey to assess and build infrastructures that provide scalable processing performance, data management, and security

HERNDON, Va., Feb. 1, 2024 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS) (news) today announced the availability of AI Ignite, a comprehensive suite of AI Solutions and Services designed to help organizations at any stage of their AI Journey to assess, enable, secure, implement and amplify the use of AI technologies.

Whether an organization is AI Curious, AI Ready, or AI Mature, the variety of solutions and services offered by ePlus will enable it to explore, build, adopt and optimize AI applications.

AI Ignite provides a suite of AI-focused offerings supporting different customer needs across various stages of readiness, including an envisioning workshop, readiness assessments, data strategy assessments, infrastructure builds, modern platform management and implementation and ongoing support services. These services include:

To further support customers' AI development and innovation needs, ePlus is also building a state-of-the-art AI innovation lab designed to facilitate customer proofs-of-concept, deliver workshops and trainings, and support internal development of GenAI applications.

"There is a significant gap in AI knowledge and readiness among organizations, and ePlus' experience in areas critical to the success of AI, including data storage and security, make us the ideal partner to help bridge that gap," said Mark Marron, CEO and president, ePlus. "With AI Ignite, ePlus is providing a comprehensive suite of services that cater to the diverse needs of organizations at any stage of their AI journey. Our specialized expertise can help organizations de-mystify AI by assessing their environments, reviewing related considerations, suggesting appropriate design and support, and helping to implement or maintain it." 

"AI applications demand enormous speed and low latency, which makes having a scalable and well-tailored infrastructure design a critical factor for success," said Ken Farber president of ePlus Software, and leading partnerships, marketing and strategy at ePlus. "AI Ignite goes beyond building AI infrastructure by helping ensure excellence in performance, facilitating faster insights and operational efficiency, and empowering organizations to unlock the full potential of AI to drive meaningful business outcomes."

For more information about ePlus AI Ignite, visit www.eplus.com/AI.

About ePlus inc.

ePlus has an unwavering and relentless focus on leveraging technology to create inspired and transformative business outcomes for its customers. Offering a robust portfolio of solutions, as well as a broad range of consultative and managed services across the technology spectrum, ePlus has proudly achieved more than 30 years of success, carrying customers forward through adversity, rapidly changing environments, and other obstacles. ePlus is a trusted advisor, bringing expertise, credentials, talent and a thorough understanding of innovative technologies, spanning security, cloud, data center, networking, collaboration and emerging solutions, to organizations across all industry segments. With complete lifecycle management services and flexible payment solutions, ePlus' more than 1,850 associates are focused on cultivating positive customer experiences and are dedicated to their craft, harnessing new knowledge while applying decades of proven experience. ePlus is headquartered in Virginia, with locations in the United States, UK, Europe, and Asia?Pacific. For more information, visit www.eplus.com, call 888-482-1122, or email [email protected]. Connect with ePlus on LinkedIn, Twitter, Facebook, and Instagram. ePlus, Where Technology Means More®.

ePlus®, Where Technology Means More®, and ePlus products referenced herein are either registered trademarks or trademarks of ePlus inc. in the United States and/or other countries. The names of other companies, products, and services mentioned herein may be the trademarks of their respective owners.

Forward-Looking Statements

This press release contains information about management's view of ePlus' future expectations, plans and prospects that are not historical facts and may be deemed to be "forward-looking statements." Actual and anticipated future results may vary materially due to certain risks and uncertainties. Certain risks and uncertainties that may affect such "forward-looking statements" are detailed in our reports filed with the Securities and Exchange Commission, especially under the heading "Risk Factors". All information set forth in this press release is current as of the date of this release and ePlus expressly disclaims any duty or obligation to update this information, except as may be required by law.

 

SOURCE EPLUS INC.


These press releases may also interest you

30 jun 2024
NOVOSENSE Microelectronics, a global automotive chip provider, recently announced the launch of its latest product collection, delivering high-quality solutions tailored for automotive lighting, powertrain, BMS, thermal management systems. Advanced...

30 jun 2024
KKR, a leading global investment firm, and Teachers' Venture Growth (TVG), the late-stage venture and growth investment arm of Ontario Teachers' Pension Plan, today announced the signing of definitive agreements under which KKR (on behalf of funds...

30 jun 2024
At a recent event in Shanghai, Squirrel Ai unveiled its latest achievement: a multimodal Large Adaptive Model (LAM) that represents a major step forward in educational technology. The conference revealed significant upgrades to both the model and the...

30 jun 2024
Pomelo Group is proud to announce the endorsement of...

30 jun 2024
SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...

30 jun 2024
"AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New...



News published on and distributed by: